Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score

por Ebner, Florian, Salmen, Jessica, Dayan, Davut, Kiesel, Matthias, Wolters, Regine, Janni, Wolfgang, Wöckel, Achim, Wischnewsky, Manfred
Publicado 2023

Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases

por Löb, Sanja, Linsmeier, Eva, Herbert, Saskia-Laureen, Schlaiß, Tanja, Kiesel, Matthias, Wischhusen, Jörg, Salmen, Jessica, Kranke, Peter, Quenzer, Anne, Kurz, Florian, Weiss, Claire, Gerhard-Hartmann, Elena, Wöckel, Achim, Diessner, Joachim
Publicado 2022

BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients

por Wischnewsky, Manfred, Schwentner, Lukas, Diessner, Joachim, de Gregorio, Amelie, Joukhadar, Ralf, Davut, Dayan, Salmen, Jessica, Bekes, Inga, Kiesel, Matthias, Müller-Reiter, Max, Blettner, Maria, Wolters, Regine, Janni, Wolfgang, Kreienberg, Rolf, Wöckel, Achim, Ebner, Florian
Publicado 2021